Territory Manager
About the job
- A bachelor's degree and at least 2 years of sales experience in the medical device or pharmaceutical industry are required. In lieu of a degree, at least 5 years of sales experience in the medical device or pharmaceutical industry, or 3 years of previous experience at Inspire Medical Systems working directly with the therapy in a clinical setting, is accepted.
- Strong computer skills with Microsoft Office, including PowerPoint and Excel.
- Ability to manage simultaneous priorities and changing deadlines.
- Ability to travel, including overnight travel as needed, within the territory.
- Lead commercialization activities introducing obstructive sleep apnea therapy to the assigned sales territory.
- Achieve sales plan and therapy-awareness milestones, and assess potential new accounts within the territory.
- Drive implant growth through prompt account activation and efficient patient throughput.
- Coordinate commercial site assessment, selection, and development.
- Achieve and exceed the assigned sales quota.
- Ensure commercial centers follow patient selection guidelines, implant techniques, and effective therapy methods.
- Facilitate local payer education and development.
- Work with marketing and sales operations teams to refine and enhance organic and direct-to-patient outreach programs.
- Experience assisting with implantation and follow-up of implantable devices.
- Experience in market development and building referral programs within the medical industry.
- Product launch and account experience.
About the company
Inspire Medical Systems develops and sells a minimally invasive implantable device for obstructive sleep apnea (OSA). Its lead product, the Inspire system, uses implanted neurostimulation to activate the hypoglossal nerve, which moves the tongue and other airway muscles to keep the airway open during sleep. Patients control the therapy with a small handheld remote. The system targets adults with moderate to severe OSA who cannot use or benefit consistently from CPAP. Unlike non-implant options, Inspire provides a hands-free, on-demand airway support during sleep and is the first FDA-approved neurostimulation treatment for OSA. The company differentiates itself by offering a clinically approved implantable alternative to CPAP, backed by a direct US sales force and a network in Europe. Its goal is to provide an effective, durable option for patients who struggle with CPAP, expanding access to neurostimulation therapy to improve sleep quality and health outcomes.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Golden Valley, Minnesota
Founded
2007
Get referred to Inspire Medical Systems
See people who can refer or advise you
Simplify's Take
What believers are saying
- August 2026 Project Horizon targets $30 million annualized investment capacity by 2027.
- September 2026 conference materials said coding clarity improved and WISeR-state billing issues eased.
- CMS proposed 2027 facility-rate increases of 12% to 15%, supporting procedure economics.
What critics are saying
- The January 2026 class action alleges Inspire V launch failures and misleading disclosures.
- Medicare coding disruption cut second-quarter revenue $40 million; management expects $120 million-$130 million full-year impact.
- If reimbursement stalls again before 2028 CPT approval, Inspire's growth thesis breaks quickly.
What makes Inspire Medical Systems unique
- Inspire remains the only FDA-approved hypoglossal nerve stimulator for moderate-to-severe OSA.
- The 2026 launch of Inspire V strengthened procedure simplicity and 3.0T MRI compatibility.
- Direct U.S. sales and distributor coverage give Inspire tight control over adoption and education.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Health Savings Account/Flexible Spending Account
- 401(k) Retirement Plan
- 401(k) Company Match
- Unlimited Paid Time Off
- Tuition Reimbursement
- Employee Assistance program
- Employee Stock Purchase Plan